Filing Details
- Accession Number:
- 0000899243-17-026032
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-11-13 16:26:06
- Reporting Period:
- 2017-11-13
- Accepted Time:
- 2017-11-13 16:26:06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1492422 | Apellis Pharmaceuticals Inc. | APLS | Pharmaceutical Preparations (2834) | 271537290 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1543112 | Ltd Investments Venture Morningside | 2Nd Floor, Le Princce De Galles 3-5 Avenue Des Citronniers Mc 98000 O9 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-11-13 | 10,778,303 | $0.00 | 10,778,303 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2017-11-13 | 575,000 | $14.00 | 11,353,303 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series B Preferred Stock | Disposition | 2017-11-13 | 1,054,544 | $0.00 | 494,394 | $0.00 |
Common Stock | Series C Preferred Stock | Disposition | 2017-11-13 | 17,200,000 | $0.00 | 8,063,759 | $0.00 |
Common Stock | Series D Preferred Stock | Disposition | 2017-11-13 | 4,476,275 | $0.00 | 2,098,581 | $0.00 |
Common Stock | Series E Preferred Stock | Disposition | 2017-11-13 | 259,302 | $0.00 | 121,566 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Direct | ||
0 | No | 4 | C | Direct | ||
0 | No | 4 | C | Direct | ||
0 | No | 4 | C | Direct |
Footnotes
- The Series B, Series C, Series D and Series E Preferred Stock converted into Common Stock on a 2.133-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B, Series C, Series D and Series E Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
- Louise Mary Garbarino, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments, Ltd. ("MVIL"), share voting and dispositive control over the shares held by MVIL.